Key terms
About DiaSorin S.p.A. 0.0% 05-MAY-2028
Sector
Health Technology
Industry
Medical Specialties
Home page
ISIN
XS2339426004
DiaSorin SpA engages in developing, producing and marketing reagent kits for laboratory diagnostics. It operates through following segments Immunodiagnostics, Molecular Diagnostics, and Life Science. The Immunodiagnostics segment engages in the development of new tests based on complex algorithms. The Molecular Diagnostics segment focuses on providing specialty tests and complex multiplex solutions. The Life Science segment offers diagnostic instruments and technology. The firm provides clinical services in areas like Infectious diseases, bone and mineral, endocrinology, hypertension, oncology, stool diagnostics and autoimmunity. The company was founded in 1968 and is headquartered in Saluggia, Italy.
Related bonds
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.